11 results
DEF 14A
CMRA
Comera Life Sciences Holdings, Inc.
11 Aug 23
Definitive proxy
4:15pm
of Biologically Inspired Engineering since October 2020. Under Dr. Muni’s tenure at Azurity as CEO, he led two successful private equity transactions
PRE 14A
CMRA
Comera Life Sciences Holdings, Inc.
1 Aug 23
Preliminary proxy
5:08pm
at Harvard University’s Wyss Institute of Biologically Inspired Engineering since October 2020. Under Dr. Muni’s tenure at Azurity as CEO, he led two
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
. Under Dr. Muni’s tenure at Azurity as CEO, he led two successful private equity transactions including recapitalization and company sale, and oversaw
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
Engineering since October 2020. Under Dr. Muni’s tenure at Azurity as CEO, he led two successful private equity transactions including recapitalization
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:32pm
. Muni’s tenure at Azurity as CEO, he led two successful private equity transactions including recapitalization and company sale, and oversaw the FDA
424B3
ioj1vi qh0vh5sv2biog
15 Sep 22
Prospectus supplement
4:09pm
424B3
4cvh9d0s
28 Jun 22
Prospectus supplement
10:45am
S-1
oxfkur81 sirqi4
4 May 22
IPO registration
9:23pm
- Prev
- 1
- Next